These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15309539)
21. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125 [TBL] [Abstract][Full Text] [Related]
22. Renal interstitial atp responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Nishiyama A; Majid DS; Walker M; Miyatake A; Navar LG Hypertension; 2001 Feb; 37(2 Pt 2):753-9. PubMed ID: 11230369 [TBL] [Abstract][Full Text] [Related]
24. Studies on the tubulo-glomerular feedback system in the rat. The mechanism of reduction in filtration rate with benzolamide. Tucker BJ; Steiner RW; Gushwa LC; Blantz RC J Clin Invest; 1978 Nov; 62(5):993-1004. PubMed ID: 711863 [TBL] [Abstract][Full Text] [Related]
25. The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. Henrich WL; Anderson RJ; Berns AS; McDonald KM; Paulsen PJ; Berl T; Schrier RW J Clin Invest; 1978 Mar; 61(3):744-50. PubMed ID: 641152 [TBL] [Abstract][Full Text] [Related]
26. Adenosine A2 receptor-mediated regulation of renal hemodynamics and glomerular filtration rate is abolished in diabetes. Persson P; Hansell P; Palm F Adv Exp Med Biol; 2013; 765():225-230. PubMed ID: 22879037 [TBL] [Abstract][Full Text] [Related]
27. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Topcu SO; Pedersen M; Nørregaard R; Wang G; Knepper M; Djurhuus JC; Nielsen S; Jørgensen TM; Frøkiaer J Am J Physiol Renal Physiol; 2007 Feb; 292(2):F736-48. PubMed ID: 17032940 [TBL] [Abstract][Full Text] [Related]
28. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction). Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling renal blood flow and glomerular filtration rate. Bugge JF; Stokke ES Acta Physiol Scand; 1994 Apr; 150(4):431-40. PubMed ID: 8036911 [TBL] [Abstract][Full Text] [Related]
31. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes. Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857 [TBL] [Abstract][Full Text] [Related]
32. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans. Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911 [TBL] [Abstract][Full Text] [Related]
34. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Woods LL; Mizelle HL; Hall JE Am J Physiol; 1987 Jan; 252(1 Pt 2):F65-73. PubMed ID: 3812702 [TBL] [Abstract][Full Text] [Related]
35. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan. Cervenka L; Navar LG J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163 [TBL] [Abstract][Full Text] [Related]
36. Blood pressure, heart rate and tubuloglomerular feedback in A1AR-deficient mice with different genetic backgrounds. Kim SM; Mizel D; Qin Y; Huang Y; Schnermann J Acta Physiol (Oxf); 2015 Jan; 213(1):259-67. PubMed ID: 25182861 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats. Gekle M; Silbernagl S J Pharmacol Exp Ther; 1993 Oct; 267(1):316-21. PubMed ID: 8229758 [TBL] [Abstract][Full Text] [Related]
38. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Smilde TD; Damman K; van der Harst P; Navis G; Westenbrink BD; Voors AA; Boomsma F; van Veldhuisen DJ; Hillege HL Clin Res Cardiol; 2009 Feb; 98(2):121-9. PubMed ID: 18979056 [TBL] [Abstract][Full Text] [Related]
39. Effects of tempol and candesartan on neural control of the kidney. Eppel GA; Head GA; Denton KM; Evans RG Auton Neurosci; 2012 May; 168(1-2):48-57. PubMed ID: 22336580 [TBL] [Abstract][Full Text] [Related]
40. An investigation of the role of carbonic anhydrase in aquatic and aerial gas transfer in the African lungfish Protopterus dolloi. Perry SF; Gilmour KM; Swenson ER; Vulesevic B; Chew SF; Ip YK J Exp Biol; 2005 Oct; 208(Pt 19):3805-15. PubMed ID: 16169956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]